Chronic hyperglycemia can increase oxidative stress, reduce the tumor-suppressive activity of adenosine monophosphate-activated protein kinase, impair the diversion capacity of hexosamine monophosphate, and lead to the accumulation of advanced glycation end products, affecting the mitogen-activated protein kinase NF-KB pathway (58). Here, NFKB1 is linked to neoplasm.